Team introduces new approach in cancer therapy with innovative mechanism-of-action for ferroptosis induction

FSP1 condensates in green induced by icFSP1 surrounding a blue nucleus. Credit: Toshitaka Nakamura A team of researchers led by Dr. Marcus Conrad from Helmholtz Munich has discovered a novel…

Adagrasib effective for patients with KRAS G12C-mutant lung cancer and untreated brain metastases

Credit: Unsplash/CC0 Public Domain Researchers from The University of Texas MD Anderson Cancer Center found the KRAS G12C inhibitor adagrasib showed promising activity suppressing cancer growth not only within the…

Adhering to global health recommendations reduces cancer risk

Credit: CC0 Public Domain People who adhere to global Cancer Prevention Recommendations are putting themselves at lower risk of developing the disease, new research confirms. Experts at Newcastle University have…

Cancer has an obesity-related risk factor, and it depends on sex and cancer type

Graphical abstract. Credit: Cancer Cell (2023). DOI: 10.1016/j.ccell.2023.05.010 Obesity has been previously linked to an increased risk of cancer, but most studies have not differentiated the risks between male and…

Why some women should receive more than mammograms to screen for breast cancer

Credit: Unsplash/CC0 Public Domain Dense breast tissue, which contains a higher proportion of fibrous tissue than fat, is a risk factor for breast cancer and also makes it more difficult…

Genetic counseling for familial colorectal cancer can provide significant improvements in patient empowerment

Credit: Unsplash/CC0 Public Domain Genetic counseling is essential when dealing with individuals who are affected by, or at risk of, inherited disease. Although it is known to be useful in…

Scientists get closer to a better PSA test

The most common screening test for prostate cancer so often returns a false positive result that it’s no longer recommended for men older than 70, and it’s offered as a…

Fixed-duration ibrutinib plus venetoclax may benefit patients with high-risk chronic lymphocytic leukemia

Credit: CC0 Public Domain First-line ibrutinib (Imbruvica) plus venetoclax (Venclexta) led to high response and survival rates in patients with chronic lymphocytic leukemia (CLL) whether or not their cancer harbored…

New advances in fighting a range of cancers

Credit: Pixabay/CC0 Public Domain New advances in the fight against a range of cancers have been revealed at the annual meeting of the American Society of Clinical Oncology (ASCO), which…

Real-world data suggests stopping immunotherapy after two years is reasonable in patients with advanced lung cancer

Credit: Pixabay/CC0 Public Domain Over the past decade, the approval of immune checkpoint inhibitors has revolutionized treatment for patients with advanced lung cancer, helping many live longer lives and improving…